ArticleJACC. Case reports2025

Reply: Belatacept as an Emerging Option in Immunosuppression-Induced Thrombotic Microangiopathy After Heart Transplantation.

Faysal Massad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.